About Mylin Biotech
Mylin Biotech is a company. The company has 15 employees as of April 06, 2024. Mylin Biotech offers products and services including ZAVETOX and Aminase.
- Employees 15 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Mylin Biotech India Pvt. Ltd
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$292.19 K (USD)26.95as on Mar 31, 2023
-
Net Profit
-$26.04 K (USD)-263.17as on Mar 31, 2023
-
EBITDA
$37.06 K (USD)8.92as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
15
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mylin Biotech
Mylin Biotech offers a comprehensive portfolio of products and services, including ZAVETOX and Aminase.
This product is utilized for managing gut dysbiosis and related chronic diseases through therapeutic combinations.
This service is employed for enhancing protein breakdown and assimilation in conditions like protein energy malnutrition.
Funding Insights of Mylin Biotech
Detailed funding history for Mylin Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mylin Biotech
Investment portfolio details for Mylin Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mylin Biotech
Detailed financials for Mylin Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mylin Biotech Comparisons
Peer comparison for Mylin Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mylin Biotech
Detailed competitors of Mylin Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mylin Biotech
Complete news archive for Mylin Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mylin Biotech
As of Apr 06, 2024, the latest employee count at Mylin Biotech is 15.
Annual revenue of Mylin Biotech is $292.19K as on Mar 31, 2023.
It is noted that Mylin Biotech was established in 2012 as a research and innovation organization, where efforts are directed towards overcoming gut-mediated diseases through synbiotics, enzobiotics, and enzotein research. The companys commitment to gut health is evident in its exploration of axes like Gut-Kidney and Gut-Liver, with products undergoing rigorous testing and validation to address chronic conditions such as kidney disease and liver cirrhosis. Patent applications in multiple countries reflect the emphasis placed on quality and innovation in healthcare solutions, ensuring therapies are disseminated to professionals for patient benefit. Overall, a personalized approach to metabolic signatures is pursued to enhance well-being.
Mylin Biotech offers ZAVETOX and Aminase.